MyndTec, an award-winning Canadian medical technology company announced today it has received 510(k) clearance to market its landmark product MyndMove®. MyndTec is a pioneer in the treatment of arm and hand paralysis caused by stroke or spinal cord injury.
“This is a major milestone in the evolution of our company. We are delighted that we can now offer this life-changing therapy to patients in the U.S. with upper extremity paralysis.”
For the full press release click here